Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

62.07 +3.41 (+5.81%)
Official Closing Price Updated: 4:15 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,631,139
Open 60.00
Bid (Size) 62.16 (5)
Ask (Size) 62.30 (5)
Prev. Close 58.66
Today's Range 58.60 - 63.67
52wk Range 22.89 - 91.45
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Shares of Tempus AI Are Jumping Higher This Week
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
+81.2%
+81.2%
1 Month
+5.6%
+5.6%
3 Month
+26.4%
+26.4%
6 Month
+23.1%
+23.1%
1 Year
+54.2%
+54.2%

More News

Read More
Update! What Is Congress Trading So Far In 2025?
Via MarketBeat
TEMPUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Tempus AI, Inc. on Behalf of Tempus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Tempus AI Stock Soared 15% Today
Via The Motley Fool
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
From Pomerantz LLP
Via GlobeNewswire
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
Tempus AI Stock Rockets After Introduction Of Liquid Biopsy Assay For Cancer Treatment Monitoring: Retail Hopes For A 20% Rally
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tempus AI Stock Is Surging Today: What Investors Are Watching
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers
From Tempus AI, Inc.
Via Business Wire
Introducing Tempus One in the EHR with Integrated Guidelines
From Tempus AI, Inc.
Via Business Wire
Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model
From Tempus AI, Inc.
Via Business Wire
Tempus AI Stock: Buy the Dip, or Is the Short-Seller Right?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Tempus AI Stock Plummeted This Week
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Real-World Deployments Signal AI Healthcare Is Ready for Scale
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting
From Tempus AI, Inc.
Via Business Wire
Tempus: Short Seller Attack Brings Golden Opportunity Cathie Wood Was Waiting For
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia, Apple, Amazon, Tempus AI, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Tempus AI, Inc. (NASDAQ: TEM) Securities Fraud Investigation; Investors Urged to Contact Award-Winning Firm, Gibbs Mura
From Gibbs Mura
Via Business Wire
Cathie Wood Ditches $5.6M More Tesla While Elon Musk Quits Government Role — Doubles Down On AI Stock Under Attack By Short Sellers
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Rosen Law Firm Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation – TEM
From The Rosen Law Firm, P.A.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Tempus AI, Inc. – TEM
From Pomerantz LLP
Via GlobeNewswire
A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today
Via The Motley Fool
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities

Frequently Asked Questions

Is Tempus AI, Inc. - Class A Common Stock publicly traded?
Yes, Tempus AI, Inc. - Class A Common Stock is publicly traded.
What exchange does Tempus AI, Inc. - Class A Common Stock trade on?
Tempus AI, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tempus AI, Inc. - Class A Common Stock?
The ticker symbol for Tempus AI, Inc. - Class A Common Stock is TEM on the Nasdaq Stock Market
What is the current price of Tempus AI, Inc. - Class A Common Stock?
The current price of Tempus AI, Inc. - Class A Common Stock is 62.07
When was Tempus AI, Inc. - Class A Common Stock last traded?
The last trade of Tempus AI, Inc. - Class A Common Stock was at 06/06/25 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.